Specific Use-result Surveillance of Spiriva Respimat in asthmatics (patients with mild to moderate persistent asthma)

First published 22/06/2017

Last updated 20/10/2026

EU PAS number:

EUPAS19173

Study

Finalised

Download as PDF

Documents

Study protocol

Updated protocol

0205-0525_protocol_redacted.pdf

First published: 10/12/2025

English (539.05 KB - PDF) View document

Study results

0205-0525_Synopsis.pdf

English (219.28 KB - PDF) View document

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Specific Use-result Surveillance of Spiriva Respimat in asthmatics (patients with mild to moderate persistent asthma)

Secondary tabs

Share this page